Bococizumab (Anti-PCSK9)
Bococizumab (Anti-PCSK9) is a humanized monoclonal IgG2Δa antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used for the treatment of hyperlipidemia. MW: 145.06 kD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2788 |
| Sku # | A2788-1mg*5 |
| Pricing | 1mg*5, $1390.00 |